Motor neurone disease (ALS)
Neurology · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A progressive neurodegenerative disease of upper and lower motor neurones causing weakness, wasting and bulbar failure with preserved sensation. Care is multidisciplinary and anticipatory — protecting breathing, swallowing and communication — with riluzole to modestly slow progression. First action: refer to a specialist neuromuscular/MND service.
Red flags
- Refer promptly to a neuromuscular/MND specialist service for diagnosis and coordinated care
- Involve respiratory and palliative teams early
- Admit for acute respiratory decompensation, aspiration or feeding crises — within the agreed ceiling of care
Assessment
Investigations
- Primarily clinical
- EMG/nerve conduction studies show widespread denervation with normal sensory studies
- MRI brain/spine to exclude mimics (cord compression, MS)
- Bloods to exclude treatable causes; genetic testing where indicated
- Baseline and serial respiratory function (FVC, SNIP)
Management
- Specialist MDT care
- Riluzole modestly prolongs survival; consider other approved disease- modifying agents where available
- Non-invasive ventilation improves survival and symptoms in respiratory decline
- Nutrition support and timely gastrostomy for dysphagia
- Manage spasticity, cramps, drooling (sialorrhoea), communication aids, and provide early advance- care planning and palliative support
Disposition
Refer promptly to a neuromuscular/MND specialist service for diagnosis and coordinated care.
Complications & pitfalls
- Respiratory failure (the usual cause of death), aspiration pneumonia, malnutrition, immobility complications, communication loss, and emotional/cognitive impact
Exam pearls
- Mixed upper and lower motor neurone signs (brisk reflexes in a wasted, fasciculating limb) with completely normal sensation is the clinical fingerprint of MND — and respiratory function, not limb power, drives prognosis, so check the FVC early.
- Monitoring & follow-up: Regular MDT review tracking respiratory function, weight/swallow, mobility and communication, with proactive intervention (NIV, gastrostomy). Psychological, carer and palliative support throughout; revisit advance decisions as the disease progresses.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.